The WWOX gene spans the common chromosomal fragile site FRA16D that is located within a massive (780 kb) intron. The WWOX gene is very long, at 1.1 Mb, which may contribute to the very low abundance of the full-length 1.4 kb mRNA. Alternative splicing also accounts for a variety of aberrant transcripts, most of which are devoid of C-terminal sequences required for WWOX to act as an oxidoreductase. The mouse WWOX gene also spans a chromosomal fragile site implying some sort of functional relationship that confers a selective advantage. The encoded protein domains of WWOX are conserved through evolution (between humans and Drosophila melanogaster) and include WW domains, an NAD -binding site, short-chain dehydrogenase/reductase enzyme and nuclear compartmentalization signals. This homology has enabled functional analyses in D. melanogaster that demonstrate roles for WWOX in reactive oxygen species regulation and metabolism. Indeed the human WWOX gene is also responsive to altered metabolism. Cancer cells typically exhibit altered metabolism (Warburg effect). Many cancers exhibit FRA16D DNA instability that results in aberrant WWOX expression and is associated with poor prognosis for these cancers. It is therefore thought that aberrant WWOX expression contributes to the altered metabolism in cancer. In addition, others have found that a specific (low-expression) allele of WWOX genotype contributes to cancer predisposition.
YunisJJSorengAL. Constitutive fragile sites and cancer. Science1984; 6: 1199–204.
2.
GloverTWArltMFCasperAMDurkinSG. Mechanisms of common fragile site instability. Hum Mol Genet2005; 14: R197–205.
3.
SteinCKGloverTWPalmerJLGlissonBS. Direct correlation between FRA3B and cigarette smoking. Genes Chrom Cancer2002; 34: 333–40.
4.
RiedKFinnisMHobsonLMangelsdorfMDayanSNancarrowJVenterDRichardsRI. Common chromosomal fragile site FRA16D DNA sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet2000; 9: 1651–63.
5.
BignellGRGreenmanCDDaviesHButlerAPEdkinsSAndrewsJMBuckGChenLBeareDLatimerCWidaaSHintonJFaheyCFuBSwamySDalglieshGLTehBTDeloukasPYangFCampbellPJFutrealPAStrattonMR. Signatures of mutation and selection in cancer genome. Nature2010; 463: 893–8.
6.
BednarekAKeck-WaggonerCLDanielRLLaflinKJBergsagelPLKiguchiKBrennerAJAldazCM. WWOX FRA16D gene behaves as a suppressor of tumour growth. Cancer Res2001; 61: 8068–73.
7.
DriouchKPrydzHMoneseRJohansenHLidereauRFrengenE. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene2002; 21: 1832–40.
8.
YangLLiuBHuangBDengJLiHYuBQiuFChengMWangHYangRYangXZhouYLuJ. A functional copy number variation in the WWOX gene is associated with lung cancer risk in Chinese. Hum Mol Genet2013; 22: 1886–94.
9.
YuKFanJDingXLiCWangJXiangYWangQS. Association study of a functional copy number variation in the WWOX gene with risk of gliomas among Chinese people. Int J Cancer2014; 135: 1687–91.
10.
O’Keefe L, Liu Y-H, Perkins A, Dayan S, Saint RB, Richards RI. FRA16D common chromosomal fragile site oxido-reductase (FOR/WWOX) protects against the effects of ionising radiation in Drosophila melanogaster. Oncogene 2005;24:6590–6 Corrigendum: Oncogene 2006;25:7662.
11.
Saluda-GorguiASetaKNowakowskaMBednarekAK. WWOX oxidoreductase – substrate and enzymatic characterization. Z Naturforsch C2011; 66: 73–82.
12.
AqeilanRIHaganJPde BruinARawahnehMSalahZGaudioESiddiquiHVoliniaSAlderHLianJBSteinGSCroceCM. Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. Endocrinology2009; 150: 153–35.
13.
Abu-OdehMBar-MagTHuangHKimTSalahZAbdeenSKSudolMReichmannDSidhuSKimPMAqeilanRI. Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multi-protein networks. J Biol Chem2014; 289: 8865–80.
14.
ChangNSPrattNHeathJSchultzLSleveDCareyGBZevotekN. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem2001; 276: 3361–70.
15.
ChangNSDohertyJEnsignALewisJHeathJSchultzLChenSTOppermannU. Molecular mechanisms underlying WOX1 activation during apoptotic and stress responses. Biochem Pharmacol2003; 66: 1347–54.
16.
KavanaghKLJornvallHPerssonBOppermannU. The SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes. Cell Mol Life Sci2008; 65: 3895–906.
17.
AqeilanRIDonatiVPalamarchukATrapassoFKaouMPekarskyYSudolMCroceCM. WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res2005; 65: 6764–72.
18.
NunezMIRosenDGLudes-MeyersJHAbbaMCKilHPageRKlein-SzantoAJGodwinAKLiuJMillsGBAldazCM. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC Cancer2005; 5: 64–64.
19.
PluciennikEKusinskaRPotemskiPKubiakRKordekRBednarekAK. WWOX – the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis. Eur J Surg Oncol2006; 32: 153–7.
20.
AqeilanRIDonatiVGaudioENicolosoMSSundvallMKorhonenALundinJIsolaJSudolMJoensuuHCroceCMEleniusK. Association of Wwox with ErbB4 in breast cancer. Cancer Res2007; 67: 9330–6.
21.
WangXChaoLMaGChenLZangYSunJ. The prognostic significance of WWOX expression in patients with breast cancer and its association with the basal-like phenotype. J Cancer Res Clin Oncol2011; 137: 271–8.
22.
Kao-ShanCSFineRLWhang-PengJLeeECChabnerBA. Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers. Cancer Res1987; 47: 6278–82.
23.
FinnisMDayanSHobsonLChenevix-TrenchGFriendKRiedKVenterDWoollattEBakerERichardsRI. Common chromosomal fragile site FRA16D mutation in cancer cells. Hum Mol Genet2005; 14: 1341–9.
24.
AqeilanRITrapassoFHussainSCostineanSMarshallDPekarskyYHaganJPZanesiNKaouMSteinGSLianJBCroceCM. Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci USA2007a; 104: 3949–54.
25.
AqeilanRIHaganJPAqeilanHAPichiorriFFongLYCroceCM. Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo. Cancer Res2007b; 67: 5606–10.
26.
Ludes-MeyersJHKilHNuñezMIContiCJParker-ThornburgJBedfordMTAldazCM. WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy. Genes Chrom Cancer2007; 46: 1129–36.
27.
Ludes-MeyersJHKilHParker-ThornburgJKusewittDFBedfordMTAldazCM. Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene. PLoS ONE2009; 4: e7775–e7775.
28.
SuzukiHTakenakaMSuzukiK. Phenotypic characterization of spontaneously mutated rats showing lethal dwarfism and epilepsy. Comp Med2007; 57: 360–9.
29.
SuzukiHKatayamaKTakenakaMAmakasuKSaitoKSuzukiK. A spontaneous mutation of the Wwox gene and audiogenic seizures in rats with lethal dwarfism and epilepsy. Genes Brain Behav2009; 8: 650–60.
30.
WhiteSHewittJTurbittEvan der ZwanYHersmusRDropSKoopmanPHarleyVCoolsMLooijengaLSinclairA. A multi-exon deletion within WWOX is associated with a 46,XY disorder of sex development. Eur J Hum Genet2012; 20: 348–51.
31.
MallaretM1SynofzikMLeeJSagumCAMahajnahMSharkiaRDrouotNRenaudMKleinFAAnheimMTranchantCMignotCMandelJLBedfordMBauerPSalihMASchüleRSchölsLAldazCMKoenigM. The tumour suppressor gene WWOX is mutated in autosomal recessive cerebellar ataxia with epilepsy and mental retardation. Brain2014; 137: 411–9.
32.
Abdel-SalamGThoenesMAfifiHHKörberFSwanDBolzHJ. The supposed tumor suppressor gene WWOX is mutated in an early lethal microcephaly syndrome with epilepsy, growth retardation and retinal degeneration. Orphanet J Rare Dis2014; 9: 12–12.
33.
O’KeefeLVColellaCDayanSChenQChooAJacobRPriceGVenterDRichardsRI. Drosophila orthologue of WWOX, the chromosomal fragile site FRA16D tumour suppressor gene, functions in aerobic metabolism and regulates reactive oxygen species. Hum Mol Genet2011; 20: 497–509.
34.
DiehnMChoRWLoboNAKaliskyTDorieMJKulpANQianDLamJSAillesLEWongMJoshuaBKaplanMJWapnirIDirbasFMSomloGGarberoglioCPazBShenJLauSKQuakeSRBrownJMWeissmanILClarkeMF. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature2009; 458: 780–3.
35.
WarburgOWindFNegeleinE. The metabolism of tumors in the body. J Gen Physiol1927; 8: 519–30.
36.
HanahanDWeinbergRA. Hallmarks of cancer: the next generation. Cell2011; 144: 646–74.
37.
ZhouSKachhapSSunWWuGChuangAPoetaLGrumbineLMithaniSKChatterjeeAKochWWestraWHMaitraAGlazerCCarducciMSidranskyDMcFateTVermaACalifanoJA. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci USA2007; 104: 7540–5.
38.
WardPSPatelJWiseDRAbdel-WahabOBennettBDCollerHACrossJRFantinVRHedvatCVPerlAERabinowitzJDCarrollMSuSMSharpKALevineRLThompsonCB. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell2010; 17: 225–34.
39.
PorporatoPEDhupSDadhichRKCopettiTSonveauxP. Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front Pharmacol2011; 2: 1–18.
MangelsdorfMRiedKWoollattEDayanSEyreHFinnisMHobsonLNancarrowJVenterDBakerERichardsRI. Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res2000; 60: 1683–9.
45.
Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res 2000;60:2140–5.
